MedTrace Logo

BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4

NCT07421648 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2026-02-19

No results posted yet for this study

Summary

This study evaluates a home-based strengthening program supported by the BandPass system, which includes a Bluetooth-enabled resistance exercise band, a mobile app that provides real-time feedback, and a clinician dashboard for remote monitoring. The goal of this clinical trial is to determine whether older adults living independently can feasibly use the BandPass system and whether participation in a BandPass-guided strengthening program improves functional performance.

The main questions this study seeks to answer are:

Whether older adults can independently and consistently use the BandPass system as part of a structured home-based strengthening program (feasibility and acceptability).

Whether the BandPass-guided program improves functional outcomes, including lower-extremity strength, mobility, and gait performance.

Participants will complete a 12-week home strengthening program using the BandPass system, attend in-person and virtual assessment visits to measure strength and mobility, and complete questionnaires related to usability, safety, and overall experience. If successful, this study will provide preliminary evidence supporting the use of remote monitoring technologies to promote strength, mobility, and independence in aging adults and inform the design of future larger-scale trials.

Conditions

Interventions

DEVICE

BandPass System

The BandPass system consists of a Bluetooth-enabled resistance exercise band paired with a mobile application that provides real-time feedback on exercise performance and transmits data to a clinician dashboard for remote monitoring. Participants will use the BandPass system for all strengthening sessions during the 8-week intervention.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • SynchroHealth LLC

    lead INDUSTRY

Principal Investigators

  • Eric Ryan, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07421648 on ClinicalTrials.gov